Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
How Badly Does India Need Biologics for Severe Asthma?
How Badly Does India Need Biologics for Severe Asthma?
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Subhabrata Moitra
,
Kalpesh T. Panchal
,
Saibal Moitra
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Clinical & Experimental Allergy
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Description
DOI:
10.1111/cea.70103
Similar Items
Tezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in Patients With Severe Asthma
by: Hazel Marriott, et al.
Published: (2026)
Asthma and Multimorbidity Amongst Ethnic Minority Groups in High Income Countries
by: Mamidipudi Thirumala Krishna, et al.
Published: (2026)
Efficacy and Safety of Subcutaneous vs. Sublingual Immunotherapy in Allergic Rhinitis: A Systematic Review and Meta‐Analysis
by: Shambo Samrat Samajdar, et al.
Published: (2024)
Penicillin Allergy Management in India and Sri Lanka: Current Challenges
by: Saibal Moitra, et al.
Published: (2025)
Biologic Prescription Patterns and Biomarker Determinants of First‐Line Dupilumab in Danish Adult Patients With Severe Asthma and Comorbid Atopic Dermatitis
by: Marianne Baastrup Soendergaard, et al.
Published: (2025)